<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="502656" id="root" date="1997-04-11" xml:lang="en">
<title>USA: Cerus starts trial of plasma system.</title>
<headline>Cerus starts trial of plasma system.</headline>
<dateline>CONCORD, Calif. 1997-04-11</dateline>
<text>
<p>Cerus Corp said it has started a Phase I clinical trial to test the safety and tolerability of its photochemical system for inactivation of pathogens in plasma used for transfusion.</p>
<p>Assuming satisfactory completion of the trial, it said it plans to begin efficacy studies in early 1988.</p>
<p>Cerus said preclinical studies showed its compounds inactivated a wide range of pathogens, such as HIV, hepatitis B and C.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-11"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-11"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-11"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-04-11"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-04-11"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="CONCORD, Calif."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
